Concepedia

Hawa Diallo

HD

10

Publications

1.5K

Citations

10

H-Index

2006

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

GlaxoSmithKline (Germany)

GlaxoSmithKline (United States)

AstraZeneca (United Kingdom)

The Gurdon Institute

Hawa Diallo is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, drug discovery, and natural sciences.

Top concepts

MedicineDrug DiscoveryNatural SciencesBiochemistryChemical BiologyMedicinal ChemistryPharmacologyMolecular BiologyCell BiologyDrug Development

Publications per year

2006–2016

10

Publications

10

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

Laurens Kruidenier, Chun‐wa Chung, Zhongjun Cheng et al. · Nature · 2012 · 932 citations · Full text

Inflammation, Cytokine, Inflammatory Disease +12

Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides

Paul Bamborough, Hawa Diallo, Jonathan D. Goodacre et al. · Journal of Medicinal Chemistry · 2011 · 176 citations · Full text

Combinatorial Chemistry, Drug Target, Bioorganic Chemistry +19

Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors

Paul Bamborough, Chun‐wa Chung, Rebecca C. Furze et al. · Journal of Medicinal Chemistry · 2015 · 83 citations · Full text

Molecular Docking, Combinatorial Chemistry, Medicinal Chemistry +14

Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors

Emmanuel H. Demont, Chun‐wa Chung, Rebecca C. Furze et al. · Journal of Medicinal Chemistry · 2015 · 78 citations · Full text

Molecular Docking, Atpase Family, Medicinal Chemistry +15

A Chemical Probe for the ATAD2 Bromodomain

Paul Bamborough, Chun‐wa Chung, Emmanuel H. Demont et al. · Angewandte Chemie International Edition · 2016 · 75 citations · Full text

Rows per page

1–5 of 10